JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HOFFMAN, J. S.
Right arrow Articles by DOMINO, E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HOFFMAN, J. S.
Right arrow Articles by DOMINO, E. F.
Journal of Pharmacology And Experimental Therapeutics, Vol. 170, Issue 2, 190-198, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


COMPARATIVE EFFECTS OF RESERPINE ON THE SLEEP CYCLE OF MAN AND CAT

JOEL S. HOFFMAN 1 and EDWARD F. DOMINO 1

1 Michigan Neuropsychopharmacology Research Program, Department of Pharmacology, University of Michigan, Ann Arbor, Michigan

Previously published studies of the effects of reserpine on rapid eye movement (REM) sleep in man and cat reported divergent results. These discrepancies indicated a need to determine the effect of single doses of reserpine on both the cat and the human sleep cycle. Human volunteers were studied for seven consecutive nights, and cats were studied for six consecutive 24-hour periods. The dose scale utilized was 0.01, 0.04 and 0.14 to 0.16 mg/kg of reserpine i.m. for both the humans and the cats. Reserpine depressed slow-wave or non-rapid eye movement sleep in both man and cat. In the cat, the duration of this dose-related effect was 24 to 36 hours; in man the effect was seen on the night of reserpine administration as well as the two or three subsequent nights. REM sleep was greatly depressed for 48 hours in the cat, and no rebound phenomena were seen. However, in man, although REM sleep was sharply decreased on the night of reserpine administration, there was a large dose-related increase on subsequent nights (35-66% of total sleep time on the second night after reserpine), which exceeded the deficit incurred on the night of reserpine administration. The prolonged effect of large doses of reserpine on slow-wave sleep and initial depression of REM sleep in cat and man and yet the marked difference between cat and man of subsequent effects on REM sleep indicate important species similarities as well as differences that must be considered in the pharmacology of sleep.

Submitted on April 21, 1969
Accepted on September 3, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.